Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse

Abstract Background Relapse of disease is frequent in anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). It is unclear whether persistent ANCA when starting maintenance therapy increases the risk of relapse. We examined the association between ANCA status and relapse in two rando...

Full description

Bibliographic Details
Main Authors: Matthew David Morgan, Matthew Szeto, Michael Walsh, David Jayne, Kerstin Westman, Niels Rasmussen, Thomas F. Hiemstra, Oliver Flossmann, Annelies Berden, Peter Höglund, Lorraine Harper, on behalf of the European Vasculitis Society
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Arthritis Research & Therapy
Subjects:
ANCA
Vasculitis
Relapse
Treatment
ANCA-associated vasculitis
Clinical trial
Online Access:http://link.springer.com/article/10.1186/s13075-017-1321-1

Internet

http://link.springer.com/article/10.1186/s13075-017-1321-1

Similar Items